Thermo Fisher Launches TrueMark Infectious Disease Research Panels

Thermo Fisher Scientific, the global leader in serving science, announced the launch of the TrueMark Infectious Disease Research Panels designed to enable rapid and precise detection and categorization for investigating microorganisms that cause respiratory, vaginal, urinary, gastrointestinal, and sexually transmitted diseases.

To effectively study outbreaks and determine disease etiology where pathogens are similar, analytically sensitive panels are needed to support laboratory research. TrueMark Infectious Disease Research Panels are analytically sensitive, real-time polymerase chain reaction (PCR) syndromic panels for the analysis of a wide range of infectious disease pathogens.

Assays can detect more than 90 different disease pathogens

Leveraging real-time PCR technology, the predefined and customizable panel options allow researchers to choose from more than 90 different bacterial and viral strain assays to generate results within four hours from taking the samples.

Dr. Manoj Gandhi, senior medical director of Genetic Testing Solutions at Thermo Fisher Scientific said:

“With the TrueMark Infectious Disease Research Panels, laboratories can choose either the readymade panels or create their own custom panels to suit their needs.”

“By providing the flexibility to choose panels for researching polymicrobial infections, laboratories can now expand their testing menus using existing instrumentation and offer the benefits of PCR testing for researching a broad range of markers that can cause infectious disease.”

The assays use pre-spotted and dried down TaqMan plates, which are designed to enable easy set-up and increased accuracy. Testing can be done from nasopharyngeal swabs or nasopharyngeal aspirate, vaginal, genital and lesion swabs or urine samples. These samples can also be prepared using workflows that currently exist in most labs that use the Applied Biosystems MagMAX Viral/Pathogen kits automated on a KingFisher Purification System instrument and mixed with the Applied Biosystems multiplex master mix onto a 96-well or 384-well plate.

Photo by CDC on Unsplash: This illustration depicted a three-dimensional (3D), computer-generated image, of a group of Gram-negative, Chlamydia psittaci bacteria. The artistic recreation was based upon scanning electron microscopic (SEM) imagery.

The panels are optimized for use on QuantStudio qPCR systems with verified sample-to-answer workflow and provide easy-to-read results with the Applied Biosystems QuantStudio Design and Analysis Software v2.6. For more information on the TrueMark Infectious Disease Research Panels, please visit www.thermofisher.com/truemarkpluspanels.

For Research Use Only. Not for use in diagnostic procedures.


Original Source – CARLSBAD, Calif.–(BUSINESS WIRE)- December 06, 2022 -Thermo Fisher Scientific: https://www.businesswire.com/news/home/20221206005003/en/Thermo-Fisher-Scientific-Launches-TrueMark-Infectious-Disease-Research-Panels#


Recommended Companies

    • myPOLS Biotec logo 768x576

    myPOLS Biotec

    • DNA RNA Extraction Isolation Analysis 768x576

    BioEcho Life Sciences


More Headlines